Editorial
Jody Early
Abstract
Traditionally, American health systems have excelled at providing acute care. Biotechnology labs support this, spending billions searching for miracle drugs. World Bank data indicates the U.S. spends approximately 17% of GDP on healthcare, which may be contrast to neighboring countries, Mexico at 6% and Canada at 10%